Content area
Abstract
If Black communities are to participate in Covid-19 trials, clinicians, investigators, and pharmaceutical companies must provide convincing evidence — sufficient to overcome the extensive historical evidence to the contrary — that they are, in fact, trustworthy.
Details
Title
Trustworthiness before Trust — Covid-19 Vaccine Trials and the Black Community
Author
Warren, Rueben C; Forrow Lachlan; Hodge, David Augustin, Sr 1
1 From the National Center for Bioethics in Research and Health Care, Tuskegee University, Tuskegee, AL (R.C.W., D.A.H.); and the Center for Bioethics, Harvard Medical School, Boston (L.F., R.D.T.).
1 From the National Center for Bioethics in Research and Health Care, Tuskegee University, Tuskegee, AL (R.C.W., D.A.H.); and the Center for Bioethics, Harvard Medical School, Boston (L.F., R.D.T.).
Section
Perspective
Publication year
2020
Publication date
Nov 26, 2020
Website
ISSN
00284793
e-ISSN
15334406
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2464400235
Copyright
Copyright © 2020 Massachusetts Medical Society. All rights reserved.